Li et al. prospectively followed 73,061 cancer-free Chinese women aged 40–70 from urban Shanghai (Shanghai Women's Health Study, baseline 1997–2000) for an average of 9.1 years, during which 475 incident colorectal cancers (287 colon, 188 rectal) were confirmed via the Shanghai Cancer Registry and chart review. The multivariable-adjusted hazard ratio for the highest vs. lowest quintile of energy-adjusted glycemic load was 0.94 (95% CI: 0.71–1.24; P for trend = 0.84), with null findings for glycemic index (HR 1.09, CI 0.81–1.46) and total carbohydrate intake (HR 0.87, CI 0.66–1.15) . Notably, middle glycemic-load quintiles showed inverse HRs (0.69–0.74), likely reflecting confounding by the healthier/lower-meat dietary profile of higher-GL consumers (older, more physically active, lower red meat intake) rather than a protective carbohydrate effect.
All five quintiles' confidence intervals span 1.0 (or cross it between adjacent categories), visually confirming the null. Results were robust: subsite analyses (colon vs. rectum), exclusion of first-year cases (HR 1.06), restriction to dual-FFQ completers (HR 1.06), and exclusion/censoring of diabetics (HR 1.06) all changed estimates minimally. Effect modification by BMI, physical activity, and three dietary patterns was absent (all P for interaction ≥0.09). Rice, contributing 69% of carbohydrates and 80% of glycemic load, was itself unassociated (highest quintile HR 1.17, CI 0.87–1.57) .
The finding aligns with a meta-analysis of 8 cohorts (pooled RR 1.06, CI 0.96–1.17) and most Western prospective studies, while contrasting with case-control studies reporting odds ratios of 1.59–1.82 — a pattern classic for recall bias and selection bias in retrospective designs . Two tensions deserve attention. First, among diagnosed stage III colon cancer patients, post-diagnosis glycemic load was associated with sharply higher recurrence and mortality (HR 1.97, CI 1.39–2.79), suggesting glycemic load may matter for tumor progression even if not for primary incidence . Second, broader reviews of GI/GL and chronic disease report inconsistent associations across outcomes, consistent with this null .
The design comparison chart illustrates the strongest pattern in this literature: retrospective designs cluster above 1.0; prospective designs cluster near 1.0 or below. BGPT inference: this gradient is more plausibly explained by methodological artifacts (recall bias, reverse causation, healthy-user confounding in case-control settings) than by design-specific biology.
Bottom line: a high-quality, well-powered null study. Confidence in the reported null is moderate-to-high for this population and exposure range; it should not be extrapolated to populations consuming very high-GL diets, to men, or to post-diagnosis progression, where evidence points the other way.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.